 |
Spago NanomedicalSpago Nanomedical develops nanomedical agents for diagnostics and treatment of cancer. The company´s unique nanoparticles are designed to selectively accumulate in tumors and provide excellent properties for use as contrast agent or radionuclide therapy;
SpagoPix is a gadolinium-free, tumor selective contrast agent for MRI with exceptional signal strength (relaxivity). It has demonstrated proof-of-concept in different tumor models and good safety in regulatory preclinical studies. The first clinical study in cancer patients is currently in preparation.
Tumorad® is a new radionuclide therapy for treatment of solid tumors. It is designed to passively accumulate in tumour tissue to deliver an optimized radiation dose. The project is in preclinical stage.
Spago Nanomedical aim to develop it´s projects into clinical trials and seek strategic licensing partners for further development and commercialization.Scheelevägen 22
22363 Lund
Sweden
|
| |
| |
|
Bayer AG6 West Belt
Wayne, NJ, USA 07470-6806
|
| |
| |
| |
|
Covidien675 McDonnell Blvd.
Hazelwood, MO, USA 63042
|
| |
| |
|
GuerbetP.O. Box 50400
Charles De Gaulle Cedex
Roissy
France 95943
|
| |
|
MedradOne Medrad Dr.
Indianola, PA, USA 15051-0780
|
|
MEDTRON AGHauptstrasse 255
D-66128 SAARBRÜCKEN
Germany
|
| |
| |
| |
| |
|
SupertechPO Box 186
Elkhart, Indiana, USA 46515
|
| |
|
TargesonMS 02/606
3550 General Atomics Court
San Diego, CA, USA 92121
|
| |
| |
|
Vivid Imaging7345 South Durango Drive
Building B, Suite 107/181
Las Vegas, NV, USA 89113
|
